136 related articles for article (PubMed ID: 1275477)
21. [Carminomycin study in breast cancer].
Lichinitser MR; Assekritova IV; Gorbunova VA; Arseriĭ SA; Vaarik KhM
Antibiotiki; 1978 May; 23(5):453-7. PubMed ID: 350145
[TBL] [Abstract][Full Text] [Related]
22. [Toxicity and cumulative properties of carminomycin, rubomycin and adriamycin at different times of use].
Lichinitser MR; Syrkin AB
Antibiotiki; 1976 Nov; 21(11):1030-2. PubMed ID: 1020931
[TBL] [Abstract][Full Text] [Related]
23. [Intensification of the cytostatic action of adriamycin and carminomycin by amphotericin B].
Makukho LV; Volkolupova OP; Gauze GF
Antibiotiki; 1980 Apr; 25(4):294-6. PubMed ID: 7369735
[TBL] [Abstract][Full Text] [Related]
24. [Morphological changes in the digestive organs on the administration of the antineoplastic antibiotics, rubomycin and carminomycin].
Ryzhov AI; Fomina TI
Antibiotiki; 1978 Feb; 23(2):125-8. PubMed ID: 629523
[TBL] [Abstract][Full Text] [Related]
25. [Effect of the multiple peroral administration of carminomycin on the body of animals].
Gol'dberg LE; Vertogradova TP; Filippos'iants ST; Belova IP; Shepelevtseva NG
Antibiotiki; 1978 Jul; 23(7):611-7. PubMed ID: 677851
[TBL] [Abstract][Full Text] [Related]
26. Observations on the mechanism of hemorrhagic toxicity in mithramycin (NSC 24559) therapy.
Monto RW; Talley RW; Caldwell MJ; Levin WC; Guest MM
Cancer Res; 1969 Mar; 29(3):697-704. PubMed ID: 5773813
[No Abstract] [Full Text] [Related]
27. American experience with carminomycin.
Baker LH; Kessel DH; Comis RL; Reich SD; DeFuria MD; Crooke ST
Cancer Treat Rep; 1979 May; 63(5):899-902. PubMed ID: 110446
[No Abstract] [Full Text] [Related]
28. [Antitumor activity and the effect on immunogenesis of combinations of rubomycin and carminomycin with levamisole].
Vatin AE; Filatov PP
Antibiotiki; 1982 Apr; 27(4):284-7. PubMed ID: 6896414
[TBL] [Abstract][Full Text] [Related]
29. [Use of carminomycin in bladder cancer].
Zak BI; Korol'chuk VP; Abrazheev VG; Vakulina TI; Skriabnev GA
Vopr Onkol; 1979; 25(2):63-4. PubMed ID: 371127
[No Abstract] [Full Text] [Related]
30. Comparative toxicity of carminomycin, rubomycin and adriamycin in mice and experience with carminomycin in spontaneous tumors of dogs.
Syrkin AB; Kiselev AV
Oncology; 1980; 37 Suppl 1():67-70. PubMed ID: 6935578
[TBL] [Abstract][Full Text] [Related]
31. [Comparative pathomorphological study of the experimental action of carminomycin and rubomycin on the heart].
Vinogorova GF; Khokhlova MP; Khanykova OK
Antibiotiki; 1978 Oct; 23(10):931-4. PubMed ID: 708004
[TBL] [Abstract][Full Text] [Related]
32. [Effect of antitumor preparations on the hemostatic system of oncological patients].
Zhukovskaia ES
Vopr Onkol; 1980; 26(9):22-7. PubMed ID: 7423899
[TBL] [Abstract][Full Text] [Related]
33. [Effect of the anthracycline antineoplastic antibiotics, rubomycin and carminomycin, on the glycogen and nucleic acid content in the myocardium of white mice].
Shepelevtseva NG
Antibiotiki; 1977 Jun; 22(6):553-7. PubMed ID: 883801
[TBL] [Abstract][Full Text] [Related]
34. [Effect of the anthracycline group antibiotics, mitomycin C and bruneomycin, on the transduction of drug resistance in staphylococci].
Ponomareva TR; Smolianskaia AZ
Antibiotiki; 1978 Oct; 23(10):896-902. PubMed ID: 152092
[TBL] [Abstract][Full Text] [Related]
35. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
[TBL] [Abstract][Full Text] [Related]
36. [Comparative cytogenetic action of the antitumor antibiotics, carminomycin and rubomycin].
Kurlov OV; Koĭfman EK; Gol'dberg ED
Antibiotiki; 1978 Jun; 23(6):537-40. PubMed ID: 677842
[TBL] [Abstract][Full Text] [Related]
37. [Effect of rubomycin, carminomycin and adriamycin on respiration in liver mitochondria in various metabolic states, respiratory control and ADP/O ratio].
Gorskaia IA; Suslova AI; Kotel'nikova AV
Biokhimiia; 1987 Jan; 52(1):53-7. PubMed ID: 3814654
[TBL] [Abstract][Full Text] [Related]
38. [Mechanisms of hemopoiesis inhibition and recovery after the administration of carminomycin and rubomycin in an experiment].
Novitskiĭ VV; Pichugina TV; Gol'dberg ED
Antibiotiki; 1984 Jun; 29(6):437-41. PubMed ID: 6476806
[TBL] [Abstract][Full Text] [Related]
39. Phase II clinical evaluation of 4'-epi-doxorubicin.
Hurteloup P; Cappelaere P; Armand JP; Mathé G
Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
[TBL] [Abstract][Full Text] [Related]
40. [Effect of rubomycin C on the blood system in experimental conditions].
Gol'dberg DI; Kraìushkina NP; Antipov IG
Antibiotiki; 1971 Mar; 16(3):240-3. PubMed ID: 5558685
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
